Mark has over 15 years of experience applying modeling and simulation toward optimally informing drug development decision-making. Mark’s work history has been split between pharmaceutical companies such as GSK and UCB, and companies that support the biopharmaceutical industry. He has also taught over 50 technical training workshops on modeling tools and methodology. His most recent therapeutic area experience has been with infectious disease and autoimmune disorders.
Mark Lovern, PhD Sr. Vice President, Integrated Drug Development